Skip to main content

BELLEVUE ASSET MANAGEMENT, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1801619 BELLEVUE, WA

Position in REGN

as of Mar 31, 2026 · filed Apr 24, 2026
Position Value
$20,861
+$21 QoQ
Shares Held
27
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BELLEVUE ASSET MANAGEMENT, LLC holds $175,569 across 3 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,861 27
2025-12-31 $20,840 27
2025-09-30 $16,868 30
2025-06-30 $29,925 57
2025-03-31 $36,151 57
2024-12-31 $40,602 57
2024-09-30 $59,920 57
2024-06-30 $59,908 57
2024-03-31 $54,861 57
2023-12-31 $50,062 57
2023-09-30 $46,908 57
2023-06-30 $40,956 57
2023-03-31 $46,835 57
2022-12-31 $41,124 57
2022-09-30 $39,265 57
2022-06-30 $33,694 57
2022-03-31 $39,809 57
2021-12-31 $18,314 29
2021-09-30 $17,550 29
2021-06-30 $16,197 29
2021-03-31 $13,721 29
2020-12-31 $14,010 29
2020-09-30 $16,233 29
2020-06-30 $18,085 29
2020-03-31 $14,160 29